Nurami Medical
Nurami Medical is dedicated to modernizing soft tissue repair through innovative technologies. The company specializes in developing advanced bio surgical implants using nanofibers and novel biomaterials to effectively seal and heal wounds, addressing complications associated with traditional soft tissue implants and promoting healthy tissue formation.
Nurami Medical
36 Ha-Namal St., Haifa, Israel
What We Do
ArtiFascia® is a multilayer, Dural repair graft made of biocompatible and bioabsorbable polymers with integrated barrier layer and a biomimetic structure of electrospun fibers designed to promote neodura regeneration. It is the first and only device with a 2-in-1 design: nanofibers provide a biomimetic scaffold that fosters healing + an integrated, thin film that reduces leaks. ArtiFascia® has FDA 510(k) clearance and is commercially available in the US.
Application Area
Key People
News & Updates
Nora Nseir will present Nurami at the MedTech/AdvaMed MTI showcase event.
Nurami has been chosen to receive a €2.5M from the EIC Accelerator program to support the continued development of ArtiFix, Nurami’s groundbreaking dural sealant patch.
A $4M grant investment has been approved to fund continued R&D efforts of ArtiFix and to support preliminary marketing of ArtiFascia.
A new research on neural tissue tolerance to synthetic dural mater graft implantation has been published in the Journal of Toxicologic Pathology, confirming the safety of ArtiFascia.